Target intelligence / Profile preview

Cytokine (inflammatory mediator)

Molecular classification
Other (cytokines are a broad class of small secreted proteins), Signaling molecule, Inflammatory mediator
01

Overview

Cytokines are a large family of small secreted proteins that act as **signaling molecules** in the immune system. They are released by various cells—primarily immune cells such as macrophages and helper T cells—in response to infection, injury, or other stimuli. **Inflammatory mediators** is an umbrella term that includes not only cytokines but also prostaglandins and leukotrienes; however, "cytokines/inflammatory mediators" is not itself a single molecular target but rather refers collectively to many different molecules involved in regulating inflammation[5]. Key **pro-inflammatory cytokines** include interleukin‑1 (IL‑1), interleukin‑6 (IL‑6), tumor necrosis factor alpha (**TNF–α**), interferon gamma (**IFNγ**), granulocyte-macrophage colony-stimulating factor (**GM-CSF**) and others. These molecules coordinate the body's defense against pathogens by promoting recruitment and activation of immune cells at sites of infection or injury. While essential for host defense and tissue repair during acute responses, chronic overproduction leads to diseases such as rheumatoid arthritis, cardiovascular disease, neurodegeneration, sepsis—and even cancer due to persistent tissue damage[1][4]. Therapeutic strategies often involve monoclonal antibodies that neutralize specific pro-inflammatory cytokines or block their receptors—for example anti-TNF drugs for autoimmune diseases—or use receptor antagonists like IL–1RA. However, because these therapies suppress parts of the immune system’s normal function they can increase susceptibility to infections[2]. Because "cytokines/inflammatory mediators" refers broadly to many different molecules rather than one defined target protein/receptor/gene product—and because it combines two overlapping but distinct categories—the entry is considered too generic/unspecific for structured drug-target mapping. > “An inflammatory cytokine is a type of signaling molecule...that promotes inflammation...They include interleukin‐1 (IL‐1), IL‐12...tumor necrosis factor alpha (TNF‐α)...and play an important role in mediating the innate immune response.” [1] > “Inflammatory mediators are substances released by cells in the immune system that help modulate inflammation…such as cytokines…prostaglandins…and histamine.” [5]

Other names
pro-inflammatory cytokineinflammatory cytokineinflammatory mediatorproinflammatory cytokineimmune signaling molecule
02

Mechanism of action

Neutralization of specific cytokines or blockade of their receptors to reduce pathological inflammation

03

Biological functions

Immune responseSignal transductionCell proliferationApoptosis (cell death)Regulation of inflammation
04

Disease associations

InflammationAutoimmune disease (e.g., rheumatoid arthritis)CancerCardiovascular disease (e.g., atherosclerosis)Infection/sepsisNeurodegenerative disease
05

Safety considerations

Immunosuppression leading to increased risk of infection when blocking key inflammatory pathwaysPotential for impaired healing and increased cancer risk with long-term suppression
06

Interacting drugs

Monoclonal antibodies targeting specific cytokines or their receptors (e.g., anti-TNF agents like infliximab and adalimumab; anti–IL‑6 agents like tocilizumab)
07

Biomarkers

Levels of individual cytokines such as IL‑6, TNF‑α, IL‑1β in blood or tissueC-reactive protein and other acute phase reactants as indirect markers

Beyond the preview

Go deeper on Cytokine (inflammatory mediator).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytokine (inflammatory mediator).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call